Strides Arcolab has reported results for second quarter ended September 30, 2014.
The company has reported a net profit after tax of Rs 338.47 crore for the quarter under review as compared to Rs 2.21 crore for the same quarter in the previous year. Total income of the company has increased by 8.24% at Rs 244.04 crore for Q2FY15 as compared Rs 225.47 crore for the corresponding quarter previous year.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.